Cellebrite DI (CLBT) News Today $19.13 +0.06 (+0.29%) Closing price 03:59 PM EasternExtended Trading$19.16 +0.03 (+0.18%) As of 04:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Cellebrite DI Ltd. (NASDAQ:CLBT) Shares Sold by Meitav Investment House Ltd.Meitav Investment House Ltd. cut its stake in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 33.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,370,855 shares of the company's stock after sellingFebruary 21 at 6:09 AM | marketbeat.comCellebrite DI Ltd. (NASDAQ:CLBT) is Pembroke Management LTD's 2nd Largest PositionPembroke Management LTD increased its holdings in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 4.4% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,992,432 shares of the company's stock after buyiFebruary 18 at 6:18 AM | marketbeat.comBlue Trust Inc. Makes New $468,000 Investment in Cellebrite DI Ltd. (NASDAQ:CLBT)Blue Trust Inc. purchased a new stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 21,226 shares of the company's stockFebruary 18 at 3:46 AM | marketbeat.comIs This Stock a Next-Gen Digital Forensics Leader?February 17, 2025 | fool.comCellebrite DI's (CLBT) Buy Rating Reiterated at Needham & Company LLCFebruary 17, 2025 | americanbankingnews.comCellebrite DI (NASDAQ:CLBT) Price Target Raised to $26.00 at Lake Street CapitalFebruary 16, 2025 | americanbankingnews.comLake Street Capital Issues Positive Forecast for Cellebrite DI (NASDAQ:CLBT) Stock PriceLake Street Capital increased their target price on shares of Cellebrite DI from $17.00 to $26.00 and gave the stock a "buy" rating in a report on Friday.February 15, 2025 | marketbeat.comNeedham & Company LLC Reaffirms "Buy" Rating for Cellebrite DI (NASDAQ:CLBT)Needham & Company LLC restated a "buy" rating and set a $28.00 price target on shares of Cellebrite DI in a research report on Friday.February 15, 2025 | marketbeat.comCellebrite DI (NASDAQ:CLBT) Shares Down 7.2% Following Weak EarningsFebruary 15, 2025 | americanbankingnews.comCellebrite price target raised to $30 from $25 at TD CowenFebruary 14, 2025 | markets.businessinsider.comCellebrite price target raised to $27 from $24 at Deutsche BankFebruary 14, 2025 | markets.businessinsider.comCellebrite DI Ltd (CLBT) Q4 2024 Earnings Call Highlights: Strong ARR Growth and Strategic ...February 14, 2025 | uk.finance.yahoo.comCellebrite targets 21%-25% ARR growth in 2025 with expanded customer migrationFebruary 13, 2025 | msn.comCellebrite DI Ltd. (CLBT) Q4 2024 Earnings Call TranscriptFebruary 13, 2025 | seekingalpha.comCellebrite DI Ltd. 2024 Q4 - Results - Earnings Call PresentationFebruary 13, 2025 | seekingalpha.comCellebrite reports Q4 EPS 10c, consensus 10cFebruary 13, 2025 | markets.businessinsider.comEarnings call transcript: Cellebrite Q4 2024 beats EPS forecast, stock dropsFebruary 13, 2025 | msn.comCellebrite DI (NASDAQ:CLBT) Posts Earnings Results, Misses Expectations By $0.03 EPSCellebrite DI (NASDAQ:CLBT - Get Free Report) posted its quarterly earnings results on Thursday. The company reported $0.07 earnings per share for the quarter, missing analysts' consensus estimates of $0.10 by ($0.03). Cellebrite DI had a negative net margin of 82.28% and a positive return on equity of 122.59%.February 13, 2025 | marketbeat.comCellebrite DI (NASDAQ:CLBT) Trading Down 7.2% on Disappointing EarningsCellebrite DI (NASDAQ:CLBT) Stock Price Down 7.2% After Earnings MissFebruary 13, 2025 | marketbeat.comCellebrite Announces Fourth-Quarter and Full-Year 2024 ResultsFebruary 13, 2025 | globenewswire.comCellebrite announces its Government Cloud platform achieved FedRAMP designationFebruary 12, 2025 | markets.businessinsider.comCellebrite Government Cloud Platform Achieves FedRAMP High Ready StatusFebruary 12, 2025 | globenewswire.comCellebrite DI Ltd: Value of AI, Cloud Solutions Reign in Cellebrite's 2025 Annual Industry Trends SurveyFebruary 11, 2025 | finanznachrichten.deJPMorgan Chase & Co. Forecasts Strong Price Appreciation for Cellebrite DI (NASDAQ:CLBT) StockJPMorgan Chase & Co. increased their target price on shares of Cellebrite DI from $24.00 to $28.00 and gave the company an "overweight" rating in a research report on Tuesday.February 11, 2025 | marketbeat.comValue of AI, Cloud Solutions Reign in Cellebrite's 2025 Annual Industry Trends SurveyFebruary 11, 2025 | globenewswire.comCellebrite price target raised to $28 from $24 at JPMorganFebruary 11, 2025 | markets.businessinsider.comCellebrite DI (CLBT) Receives a Buy from Lake StreetFebruary 11, 2025 | markets.businessinsider.comCellebrite DI Ltd: Cellebrite's Generative AI Innovations Deliver a Powerful Assistant to Expedite InvestigationsFebruary 6, 2025 | finanznachrichten.deCellebrite announces availability of GenAI capabilities within GuardianFebruary 6, 2025 | markets.businessinsider.comCellebrite's Generative AI Innovations Deliver a Powerful Assistant to Expedite InvestigationsFebruary 6, 2025 | globenewswire.comCellebrite DI (CLBT) Projected to Post Earnings on ThursdayCellebrite DI (NASDAQ:CLBT) will be releasing earnings before the market opens on Thursday, February 13, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=655806)February 6, 2025 | marketbeat.comCellebrite DI Ltd. (NASDAQ:CLBT) Stock Position Lowered by Y.D. More Investments LtdY.D. More Investments Ltd decreased its holdings in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 10.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 301,734 shares of the company's stock after selling 37,016 shares during the quarteFebruary 5, 2025 | marketbeat.comCalamos Advisors LLC Buys 71,120 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)Calamos Advisors LLC lifted its position in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 198.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 106,979 shares of the company's stock after buying anFebruary 5, 2025 | marketbeat.comCellebrite: Country-Wide US Adoption In The Public Sector Is RemarkableFebruary 4, 2025 | seekingalpha.comCellebrite DI: Attractive Company In Connection With AI And Digital InvestigationFebruary 4, 2025 | seekingalpha.comJanney Montgomery Scott LLC Has $1.47 Million Stock Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)Janney Montgomery Scott LLC increased its stake in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 30.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 66,487 shares of the company's stock after buying an addiFebruary 4, 2025 | marketbeat.comCellebrite DI (NASDAQ:CLBT) Reaches New 52-Week High - Still a Buy?Cellebrite DI (NASDAQ:CLBT) Reaches New 12-Month High - Here's What HappenedFebruary 3, 2025 | marketbeat.comCellebrite DI Ltd. (NASDAQ:CLBT) Short Interest UpdateCellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) was the target of a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 1,170,000 shares, a growth of 13.6% from the December 31st total of 1,030,000 shares. Currently, 1.4% of the shares of the company are sold short. Based on an average daily trading volume, of 1,310,000 shares, the short-interest ratio is currently 0.9 days.February 3, 2025 | marketbeat.comBlue Trust Inc. Buys New Shares in Cellebrite DI Ltd. (NASDAQ:CLBT)Blue Trust Inc. purchased a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 21,172 shares of the company's stockFebruary 1, 2025 | marketbeat.comCellebrite DI Ltd. (NASDAQ:CLBT) Receives Average Recommendation of "Buy" from BrokeragesShares of Cellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) have been given an average rating of "Buy" by the eight brokerages that are covering the firm, MarketBeat.com reports. Eight research analysts have rated the stock with a buy rating. The average 12 month price target among brokers that hFebruary 1, 2025 | marketbeat.comCellebrite DI (NASDAQ:CLBT) Sets New 52-Week High - Here's What HappenedCellebrite DI (NASDAQ:CLBT) Reaches New 12-Month High - Here's What HappenedJanuary 28, 2025 | marketbeat.comSG Americas Securities LLC Boosts Position in Cellebrite DI Ltd. (NASDAQ:CLBT)SG Americas Securities LLC grew its holdings in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 2,244.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 209,529 shares of the company's stock after bJanuary 25, 2025 | marketbeat.comCellebrite stock target raised, buy rating at Needham on ARR growthJanuary 24, 2025 | msn.comCellebrite price target raised to $28 from $21 at NeedhamJanuary 22, 2025 | markets.businessinsider.comCellebrite DI: Anticipated Growth Fueled by Inseyets Upgrade and US Federal Market OpportunitiesJanuary 22, 2025 | markets.businessinsider.comCellebrite DI (NASDAQ:CLBT) Hits New 1-Year High on Analyst UpgradeCellebrite DI (NASDAQ:CLBT) Hits New 12-Month High After Analyst UpgradeJanuary 22, 2025 | marketbeat.comNeedham & Company LLC Issues Positive Forecast for Cellebrite DI (NASDAQ:CLBT) Stock PriceNeedham & Company LLC increased their target price on shares of Cellebrite DI from $21.00 to $28.00 and gave the stock a "buy" rating in a report on Wednesday.January 22, 2025 | marketbeat.comJackson Square Capital LLC Makes New Investment in Cellebrite DI Ltd. (NASDAQ:CLBT)Jackson Square Capital LLC purchased a new stake in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 72,456 shares of the company's stock, valued at approximately $1,596,000. Several other hedgeJanuary 19, 2025 | marketbeat.comCellebrite DI (NASDAQ:CLBT) Reaches New 52-Week High - Time to Buy?Cellebrite DI (NASDAQ:CLBT) Hits New 12-Month High - Here's WhyJanuary 15, 2025 | marketbeat.comJPMorgan Chase & Co. Purchases 75,092 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)JPMorgan Chase & Co. raised its position in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 21.3% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 427,655 shares of the company's stock after acquiring an additional 75,092 shares during thJanuary 15, 2025 | marketbeat.com Get Cellebrite DI News Delivered to You Automatically Sign up to receive the latest news and ratings for CLBT and its competitors with MarketBeat's FREE daily newsletter. Email Address CLBT Media Mentions By Week CLBT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLBT News Sentiment▼0.330.63▲Average Business Services News Sentiment CLBT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLBT Articles This Week▼114▲CLBT Articles Average Week Get Cellebrite DI News Delivered to You Automatically Sign up to receive the latest news and ratings for CLBT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Okta News monday.com News Mobileye Global News Doximity News Rubrik News Tempus AI News Bentley Systems News Full Truck Alliance News Procore Technologies News Klaviyo News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CLBT) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellebrite DI Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellebrite DI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLBT Stock Alerts